Management of myxoid liposarcoma of the extremity (Review)
- Authors:
- Yehia Tfayli
- Ahmad Baydoun
- Ahmad Salaheddine Naja
- Said Saghieh
-
Affiliations: Division of Orthopedic Surgery, Department of Surgery, American University of Beirut Medical Center, 11‑0236 Beirut, Lebanon, Department of Surgery, Saint George Hospital University Medical Center, University of Balamand, 11‑0236 Beirut, Lebanon - Published online on: June 9, 2021 https://doi.org/10.3892/ol.2021.12857
- Article Number: 596
-
Copyright: © Tfayli et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Conyers R, Young S and Thomas DM: Liposarcoma: Molecular genetics and therapeutics. Sarcoma. 2011:4831542010.PubMed/NCBI | |
|
De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D and Ibrahim T: Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. Onco Targets Ther. 9:6233–6246. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Moreau LC, Turcotte R, Ferguson P, Wunder J, Clarkson P, Masri B, Isler M, Dion N, Werier J, Ghert M, et al: Myxoidround cell liposarcoma (MRCLS) revisited: An analysis of 418 primarily managed cases. Ann Surg Oncol. 19:1081–1088. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Haniball J, Sumathi VP, Kindblom LG, Abudu A, Carter SR, Tillman RM, Jeys L, Spooner D, Peake D and Grimer RJ: Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma. Sarcoma. 2011:5380852011. View Article : Google Scholar : PubMed/NCBI | |
|
Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, et al: Localized and metastatic myxoid/round cell liposarcoma: Clinical and molecular observations. Cancer. 119:1868–1877. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG and Gronchi A: Myxoid/round cell and pleomorphic liposarcomas: Prognostic factors and survival in a series of patients treated at a single institution. Cancer. 109:2522–2531. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng K, Yu XC, Xu M and Yang Y: Surgical outcomes and prognostic factors of myxoid liposarcoma in extremities: A retrospective study. Orthop Surg. 11:1020–1028. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al: The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343:d59282011. View Article : Google Scholar : PubMed/NCBI | |
|
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000. | |
|
Dürr HR, Rauh J, Baur-Melnyk A, Knösel T, Lindner L, Roeder F, Jansson V and Klein A: Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients. BMC Cancer. 18:3042018. View Article : Google Scholar | |
|
Wu J, Qian S and Jin L: Prognostic factors of patients with extremity myxoid liposarcomas after surgery. J Orthop Surg Res. 14:902019. View Article : Google Scholar : PubMed/NCBI | |
|
Nishida Y, Tsukushi S, Nakashima H and Ishiguro N: Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall. Clin Orthop Relat Res. 468:3041–3046. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, et al: Dose reduction of preoperative radiotherapy in myxoid liposarcoma: A nonrandomized controlled trial. JAMA Oncol. 7:e2058652021. View Article : Google Scholar : PubMed/NCBI | |
|
Greto D, Saieva C, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli J, et al: Influence of age and subtype in outcome of operable liposarcoma. Radiol Med. 124:290–300. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kilpatrick SE, Doyon J, Choong PF, Sim FH and Nascimento AG: The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 77:1450–1458. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen HJ: Biology of aging as related to cancer. Cancer. 74.(7 Suppl):S2092–S2100. 1994. | |
|
ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E and Suurmeijer AJ: Clinicopathologic prognostic factors in myxoid liposarcoma: A retrospective study of 49 patients with long-term follow-up. Ann Surg Oncol. 14:222–229. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR and Ladanyi M: Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: A molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 7:3977–3987. 2001.PubMed/NCBI | |
|
Smith TA, Easley KA and Goldblum JR: Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol. 20:171–180. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Callegaro D, Miceli R, Bonvalot S, Ferguson PC, Strauss DC, van Praag VVM, Levy A, Griffin AM, Hayes AJ, Stacchiotti S, et al: Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors. EClinicalMedicine. 17:1002152019. View Article : Google Scholar : PubMed/NCBI | |
|
Gustafson P: Soft tissue sarcoma: Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 259:2–31. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Chang HR, Hajdu SI, Collin C and Brennan MF: The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer. 64:1514–1520. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Kilpatrick SE, Ward WG and Bos GD: The value of fine-needle aspiration biopsy in the differential diagnosis of adult myxoid sarcoma. Cancer. 90:167–177. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Evans HL: Liposarcoma a study of 55 cases with a reassessment of its classification. Am J Surg Pathol. 3:507–523. 1979. View Article : Google Scholar : PubMed/NCBI | |
|
Fiore M, Ford S, Callegaro D, Sangalli C, Colombo C, Radaelli S, Frezza AM, Renne SL, Casali PG and Gronchi A: Adequate local control in high-risk soft tissue sarcoma of the extremity treated with surgery alone at a reference centre: Should radiotherapy still be a standard? Ann Surg Oncol. 25:1536–1543. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Spillane AJ, Fisher C and Thomas JM: Myxoid liposarcoma-the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol. 6:389–394. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lemeur M, Mattei JC, Souteyrand P, Chagnaud C, Curvale G and Rochwerger A: Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up. Orthop Traumatol Surg Res. 101:103–107. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bartlett EK, Curtin CE, Seier K, Qin LX, Hameed M, Yoon SS, Crago AM, Brennan MF and Singer S: Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma. Ann Surg. Jul 5–2019.(Epub ahead of print). PubMed/NCBI | |
|
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ and Rosenberg SA: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 16:197–203. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Pisters P, Harrison LB, Leung D, Woodruff JM, Casper ES and Brennan MF: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 14:859–868. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Harrison LB, Franzese F, Gaynor JJ and Brennan MF: Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 27:259–265. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Kattan MW, Leung DH and Brennan MF: Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 20:791–796. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Orson GG, Sim FH, Reiman HM and Taylor WF: Liposarcoma of the musculoskeletal system. Cancer. 60:1362–1370. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Reitan JB, Kaalhus O, Brennhovd IO, Sager EM, Stenwig AE and Talle K: Prognostic factors in liposarcoma. Cancer. 55:2482–2490. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Beane JD, Yang JC, White D, Steinberg SM, Rosenberg SA and Rudloff U: Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Ann Surg Oncol. 21:2484–2489. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Engström K, Bergh P, Cederlund CG, Hultborn R, Willen H, Aman P, Kindblom LG and Meis-Kindblom JM: Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncol. 46:838–845. 2007. View Article : Google Scholar | |
|
Knebel C, Lenze U, Pohlig F, Lenze F, Harrasser N, Suren C, Breitenbach J, Rechl H, von Eisenhart-Rothe R and Mühlhofer HML: Prognostic factors and outcome of liposarcoma patients: A retrospective evaluation over 15 years. BMC Cancer. 17:4102017. View Article : Google Scholar : PubMed/NCBI | |
|
le Grange F, Cassoni A and Seddon B: Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma. Eur J Surg Oncol. 40:394–401. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS and Pollock RE: Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 70:760–765. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Oh YJ, Yi SY, Kim KH, Cho YJ, Beum SH, Lee YH, Suh JS, Hur H, Kim KS, Kim SH, et al: Prognostic model to predict survival outcome for curatively resected liposarcoma: A multi-institutional experience. J Cancer. 7:1174–1180. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Muratori F, Bettini L, Frenos F, Mondanelli N, Greto D, Livi L, Franchi A, Roselli G, Scorianz M, Capanna R and Campanacci D: Myxoid liposarcoma: Prognostic factors and metastatic pattern in a series of 148 patients treated at a single institution. Int J Surg Oncol. 2018:89287062018.PubMed/NCBI | |
|
Gronchi A, Hindi N, Cruz J, Blay JY, Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I, Sangalli C, et al: Trabectedin and RAdiotherapy in soft tissue sarcoma (TRASTS): Results of a phase I study in myxoid liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) sarcoma groups. EClinicalMedicine. 9:35–43. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Aiba H, Yamada S, Mizutani J, Yamamoto N, Okamoto H, Hayashi K, Kimura H, Takeuchi A, Miwa S, Higuchi T, et al: Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series. PLoS One. 13:e01952892018. View Article : Google Scholar : PubMed/NCBI | |
|
Vos M, Koseła-Paterczyk H, Rutkowski P, van Leenders GJLH, Normantowicz M, Lecyk A, Sleijfer S, Verhoef C and Grünhagen DJ: Differences in recurrence and survival of extremity liposarcoma subtypes. Eur J Surg Oncol. 44:1391–1397. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Toulmonde M, Bonvalot S, Méeus P, Stoeckle E, Riou O, Isambert N, Bompas E, Jafari M, Delcambre-Lair C, Saada E, et al: Retroperitoneal sarcomas: Patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: A multicenter analysis of the French sarcoma group. Ann Oncol. 25:735–742. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Salduz A, Alpan B, Valiyev N, Özmen E, İribaş A, Ağaoğlu F, Bayram A, Bilgiç B and Özger H: Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations. Acta Orthop Traumatol Turc. 51:355–361. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chao AH, Mayerson JL, Chandawarkar R and Scharschmidt TJ: Surgical management of soft tissue sarcomas: Extremity sarcomas. J Surg Oncol. 111:540–545. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Eilber FR and Eckardt J: Surgical management of soft tissue sarcomas. Semin Oncol. 24:526–533. 1997.PubMed/NCBI | |
|
Sahu A, Sagar R, Sarkar S and Sagar S: Psychological effects of amputation: A review of studies from India. Ind Psychiatry J. 25:4–10. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker P and Wesley R: The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 196:305–315. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Chung PW, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN, Bell RS, White LM, Kandel RA and O'Sullivan B: Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: A comparison with other soft tissue sarcomas. Cancer. 115:3254–3261. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Endo M and Lin PP: Surgical margins in the management of extremity soft tissue sarcoma. Chin Clin Oncol. 7:372018. View Article : Google Scholar : PubMed/NCBI | |
|
Enneking WF, Spanier SS and Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 106–120. 1980.PubMed/NCBI | |
|
Skorpil M, Rydén H, Wejde J, Lidbrink E, Brosjö O and Berglund J: The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI. Magn Reson Imaging. 43:37–41. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, et al: Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 16:536–563. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pitson G, Robinson P, Wilke D, Kandel RA, White L, Griffin AM, Bell RS, Catton CN, Wunder JS and O'Sullivan B: Radiation response: An additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys. 60:522–526. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chowdhry V, Goldberg S, DeLaney TF, Cote GM, Chebib I, Kim J, Lozano-Calderón SA and De Amorim Bernstein K: Myxoid liposarcoma: Treatment outcomes from chemotherapy and radiation therapy. Sarcoma. 2018:80291572018. View Article : Google Scholar : PubMed/NCBI | |
|
Hatano H, Ogose A, Hotta T, Kawashima H, Sugita T, Sasamoto R and Endo N: Treatment of myxoid liposarcoma by marginal or intralesional resection combined with radiotherapy. Anticancer Res. 23:3045–3049. 2003.PubMed/NCBI | |
|
Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, et al: Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 75:48–53. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wortman JR, Tirumani SH, Tirumani H, Shinagare AB, Jagannathan JP, Hornick JL and Ramaiya NH: Neoadjuvant radiation in primary extremity liposarcoma: Correlation of MRI features with histopathology. Eur Radiol. 26:1226–1234. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Roberge D, Skamene T, Nahal A, Turcotte RE, Powell T and Freeman C: Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. Radiother Oncol. 97:404–407. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
de Vreeze RS, de Jong D, Haas RL, Stewart F and van Coevorden F: Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Radiat Oncol Biol Phys. 72:1480–1487. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Mullen JT, Hornicek FJ, Harmon DC, Raskin KA, Chen YL, Szymonifka J, Yeap BY, Choy E, DeLaney TF and Nielsen GP: Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer. 120:3676–3682. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lazarev S, McGee H, Moshier E, Ru M, Demicco EG and Gupta V: Preoperative vs postoperative radiation therapy in localized soft tissue sarcoma: Nationwide patterns of care and trends in utilization. Pract Radiat Oncol. 7:e507–e516. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR and Benjamin RS: Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: A retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 56:482–488. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
O'sullivan B and Davis AM: A randomized phase III trial of pre-operative compared to post-operative radiotherapy in extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 51:151–152. 2001. View Article : Google Scholar | |
|
Alektiar K, Brennan M and Singer S: Local control comparison of IMRT vs. brachytherapy in primary high-grade extremity Sarcoma. Int J Radiat Oncol Biol Phys. 75:S652009. View Article : Google Scholar | |
|
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults, . Meta-analysis of individual data. Sarcoma meta-analysis collaboration. Lancet. 350:1647–1654. 1997.PubMed/NCBI | |
|
Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS and Araujo DM: Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res. 2:22012. View Article : Google Scholar : PubMed/NCBI | |
|
Prestwich RJ, Taylor RE and Grimer R: Metastatic myxoid liposarcoma: Aggressive multimodality management. Clin Oncol (R Coll Radiol). 17:1302005. View Article : Google Scholar : PubMed/NCBI | |
|
Kerr LT, Donoghue JF, Wilding AL and Johns TG: Axitinib has antiangiogenic and antitumorigenic activity in myxoid liposarcoma. Sarcoma. 2016:34846732016. View Article : Google Scholar : PubMed/NCBI | |
|
Gronchi A, Hindi N, Blay JY, Redondo A, Sanfilippo R, Morosi C, Jurado JC, Fra PL, Martinez-Trufero J, Morales CMV, et al: Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase II trial in localized myxoid liposarcoma-A collaborative Spanish (GEIS), Italian (ISG) and French (FSG) group study. J Clin Oncol. 38 (15 Supppl):S115142020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M and Kirsch DG: Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma. EClinicalMedicine. 9:5–6. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wakely PE Jr, Geisinger KR, Cappellari JO, Silverman JF and Frable WJ: Fine-needle aspiration cytopathology of soft tissue: Chondromyxoid and myxoid lesions. Diagn Cytopathol. 12:101–105. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Kilpatrick SE and Ward WG: Myxofibrosarcoma of soft tissues: Cytomorphologic analysis of a series. Diagn Cytopathol. 20:6–9. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Asano N, Susa M, Hosaka S, Nakayama R, Kobayashi E, Takeuchi K, Horiuchi K, Suzuki Y, Anazawa U, Mukai M, et al: Metastatic patterns of myxoid/round cell liposarcoma: A review of a 25-year experience. Sarcoma. 2012:3451612012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim HS, Lee J, Yi SY, Jun HJ, Choi YL, Ahn GH, Seo SW, Lim DH, Ahn YC, Park JO and Kim SJ: Liposarcoma: Exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer. 9:2052009. View Article : Google Scholar : PubMed/NCBI | |
|
Rydholm A and Rööser B: Surgical margins for soft-tissue sarcoma. J Bone Joint Surg Am. 69:1074–1078. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Trovik CS: Local recurrence of soft tissue sarcoma: A Scandinavian sarcoma group project. Acta Orthop Scand. 72:1–27. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kawaguchi N, Matumoto S and Manabe J: New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol. 121:555–563. 1995. View Article : Google Scholar : PubMed/NCBI |
